News | August 19, 2007

PENN Medicine Creates GPS for the Body

August 20, 2007 - Operating under the same tracking principles as a global positioning system, the Calypso 4D Localization System, a GPS for the Body, is now available from PENN Medicine’s Department of Radiation Oncology, offering cancer patient's real-time tracking of the prostate gland during radiation treatment with IMRT or intensity-modulated radiation therapy.

The Calypso 4D Localization System works just like a GPS tracking system but for the prostate. It allows for continuous monitoring of the prostate gland during treatment. Three miniature electromagnetic sensorsveach, no bigger than a grain of rice, are implanted into the prostate during a brief outpatient procedure. Called Beacon transponders, these micro mini transmitters monitor the position and motion of the prostate in real-time, continuously sending signals to a receiver in the radiation treatment room. Before each treatment, the Calypso seeks out the "beacons" and helps the technologist to re-align the treatment plan. This system is reportedly the only one to offer "real time tracking" which helps improve the accuracy of delivering radiation.

As of now, the Calypso System is only FDA approved for prostate cancer and the first patient was treated this May.

For more information: www.med.upenn.edu

Related Content

Varian Receives FDA 510k Clearance for Halcyon Treatment System
Technology | Intensity Modulated Radiation Therapy (IMRT) | July 05, 2017
Varian Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Halcyon system,...
First New York Metropolitan Hospital Treats Cancer Patients With Accuray Radixact System
News | Image Guided Radiation Therapy (IGRT) | July 03, 2017
Accuray Inc. and Montefiore Einstein Center for Cancer Care (MECCC), part of the Montefiore Health System (MHS),...
IUCT Oncopole Installs First Radixact Radiotherapy System in France
News | Intensity Modulated Radiation Therapy (IMRT) | June 20, 2017
Accuray Inc. announced that the University Cancer Institute of Toulouse Oncopole (IUCT Oncopole) in Toulouse, France,...
cervical and endometrial cancer, IMRT, intensity modulated radiation therapy, side effects, ASTRO 2016 study
News | Intensity Modulated Radiation Therapy (IMRT) | September 29, 2016
Patients with cervical and endometrial cancer have fewer gastrointestinal and genitourinary side effects and experience...
non-small cell lung cancer, NSCLC, IMRT, toxicity, intensity modulated radiation therapy, 3-D CRT, ASTRO 2015
News | Lung Cancer | October 28, 2015
October 28, 2015 — An analysis of an international, cooperative-led trial of patients with locally advanced non-small
pediatric ependymoma patients, immediate post-surgical radiation therapy, Children's Oncology Group ACNS0121 trial, ASTRO 2015
News | Radiation Therapy | October 22, 2015
Outcomes for pediatric patients as young as 12 months with ependymoma who are treated with immediate post-operative...
post-prostatectomy IG-IMRT, image-guided intensity-modulated radiation therapy, toxicity, ASTRO, Practical Radiation Oncology
Feature | Intensity Modulated Radiation Therapy (IMRT) | October 06, 2015
A prospective study of guideline-based postoperative image-guided intensity modulated radiation therapy (IG-IMRT) in...
IMRT, chemo-radiation, oropharyngeal, head and neck cancer, combination, quality of life, study, University of Michigan
News | Intensity Modulated Radiation Therapy (IMRT) | August 14, 2015
Combining intensity-modulated radiotherapy (IMRT) with chemotherapy to treat locally advanced oropharyngeal (head and...
Overlay Init